{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:40:04Z","timestamp":1746751204001,"version":"3.40.5"},"reference-count":31,"publisher":"American Dental Society of Anesthesiology (ADSA)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:p>Emerging evidence suggests that many conventional anticonvulsants, such as carbamazepine, phenytoin, and valproic acid, could cause cross-resistance to nondepolarizing muscle relaxants. However, there are few reports describing the interactions between levetiracetam and rocuronium. This case report describes the delayed onset of rocuronium in an adult patient with intractable epilepsy on long-term levetiracetam therapy. A 33-year-old man was scheduled for extraction of third molars and restorative dental treatment. His daily levetiracetam was continued preoperatively, and after a slow mask induction, rocuronium (20 mg; 0.66 mg\/kg) was administered. Muscle relaxation was monitored by train-of-four (TOF) stimulation using the adductor muscle of the thumb. However, it took more than 9 minutes to finally obtain a TOF count of 0. This case report highlights that patients with intractable epilepsy taking levetiracetam may have resistance to rocuronium and should be carefully monitored to avoid harm triggered by prematurely initiated intubation maneuvers.<\/jats:p>","DOI":"10.2344\/23-00018","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T14:45:32Z","timestamp":1723733132000},"page":"76-80","source":"Crossref","is-referenced-by-count":0,"title":["Delayed Rocuronium Onset in a Patient Taking Levetiracetam for Epilepsy: A Case Report"],"prefix":"10.2344","volume":"71","author":[{"given":"Toru","family":"Yamamoto","sequence":"first","affiliation":[{"name":"Division of Dental Anesthesiology, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhei","family":"Koyama","sequence":"additional","affiliation":[{"name":"Division of Dental Anesthesiology, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Division of Dental Anesthesiology, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Seo","sequence":"additional","affiliation":[{"name":"Division of Dental Anesthesiology, Faculty of Dentistry & Graduate School of Medical and Dental Sciences, Niigata University, Niigata, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1191","reference":[{"issue":"3","key":"i1878-7177-71-2-76-b01","series-title":"Anaesthesia","first-page":"263","article-title":"Phenytoin-induced resistance to vecuronium","volume":"44","author":"Kumar CM,","year":"1989","unstructured":"Kumar CM,Lawler PG. Phenytoin-induced resistance to vecuronium. Anaesthesia. 1989;44(3):263\u2013264."},{"issue":"6","key":"i1878-7177-71-2-76-b02","series-title":"Anaesthesia","first-page":"520","article-title":"Phenytoin-induced resistance to vecuronium","volume":"44","author":"Gough JD,","year":"1989","unstructured":"Gough JD,Smith A,Wise CC. Phenytoin-induced resistance to vecuronium. Anaesthesia. 1989;44(6):520."},{"key":"i1878-7177-71-2-76-b03","series-title":"Anesth Analg","first-page":"665","article-title":"Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants","volume":"71","author":"Tempelhoff R,","year":"1990","unstructured":"Tempelhoff R,Modica PA,Jellish WS,Spitznagel EL. Resistance to atracurium-induced neuromuscular blockade in patients with intractable seizure disorders treated with anticonvulsants. Anesth Analg. 1990;71:665\u2013669."},{"issue":"2","key":"i1878-7177-71-2-76-b04","series-title":"Anaesth Intensive Care","first-page":"185","article-title":"Phenytoin-induced resistance to vecuronium","volume":"21","author":"Platt PR,","year":"1993","unstructured":"Platt PR,Thackray NM. Phenytoin-induced resistance to vecuronium. Anaesth Intensive Care. 1993;21(2):185\u2013191."},{"issue":"1","key":"i1878-7177-71-2-76-b05","series-title":"Anesthesiology","first-page":"109","article-title":"Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy","volume":"90","author":"Spacek A,","year":"1999","unstructured":"Spacek A,Neiger FX,Krenn CG,Hoerauf K,Kress HG. Rocuronium-induced neuromuscular block is affected by chronic carbamazepine therapy. Anesthesiology. 1999;90(1):109\u2013112."},{"issue":"4","key":"i1878-7177-71-2-76-b06","series-title":"J Neurosurg Anesthesiol","first-page":"314","article-title":"Cisatracurium-induced neuromuscular blockade in anticonvulsant treated neurosurgical patients","volume":"12","author":"Koenig MH,","year":"2000","unstructured":"Koenig MH,Edwards LT. Cisatracurium-induced neuromuscular blockade in anticonvulsant treated neurosurgical patients. J Neurosurg Anesthesiol. 2000;12(4):314\u2013318."},{"issue":"2","key":"i1878-7177-71-2-76-b07","series-title":"J Neurosurg Anesthesiol","first-page":"79","article-title":"Rocuronium-induced neuromuscular blockade is affected by chronic phenytoin therapy","volume":"13","author":"Hern\u00e1ndez-Palaz\u00f3n J,","year":"2001","unstructured":"Hern\u00e1ndez-Palaz\u00f3n J,Tortosa JA,Mart\u00ednez-Lage JF,P\u00e9rez-Ayala M. Rocuronium-induced neuromuscular blockade is affected by chronic phenytoin therapy. J Neurosurg Anesthesiol. 2001;13(2):79\u201382."},{"issue":"2","key":"i1878-7177-71-2-76-b08","series-title":"Anesth Analg","first-page":"538","article-title":"Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients","volume":"100","author":"Richard A,","year":"2005","unstructured":"Richard A,Girard F,Girard DC, et al. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Anesth Analg. 2005;100(2):538\u2013544."},{"key":"i1878-7177-71-2-76-b09","series-title":"Epileptic Disord","first-page":"409","article-title":"Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs","volume":"16","author":"Zaccara G,","year":"2014","unstructured":"Zaccara G,Perucca E. Interactions between antiepileptic drugs, and between antiepileptic drugs and other drugs. Epileptic Disord. 2014;16:409\u2013431."},{"key":"i1878-7177-71-2-76-b10","series-title":"Paediatr Anaesth","first-page":"248","article-title":"Antiepileptic drugs and anesthesia","volume":"27","author":"Bloor M,","year":"2017","unstructured":"Bloor M,Nandi R,Thomas M. Antiepileptic drugs and anesthesia. Paediatr Anaesth. 2017;27:248\u2013250."},{"key":"i1878-7177-71-2-76-b11","series-title":"Article in Japanese. Kuoshuueisei","first-page":"648","article-title":"The fundamental problem of severe mentally and physically disabled person","volume":"35","author":"Oshima K.","year":"1971","unstructured":"Oshima K. The fundamental problem of severe mentally and physically disabled person. Article in Japanese. Kuoshuueisei. 1971;35:648\u2013655."},{"key":"i1878-7177-71-2-76-b12","series-title":"Indian J Anaesth","first-page":"S108","article-title":"Evaluation of intubating conditions with rocuronium 0.6 mg\/kg using train of four stimulation in elective surgery","volume":"66","author":"Kumar N,","year":"2022","unstructured":"Kumar N,Rani D,Jain A. Evaluation of intubating conditions with rocuronium 0.6 mg\/kg using train of four stimulation in elective surgery. Indian J Anaesth. 2022;66:S108\u2013S114."},{"issue":"4","key":"i1878-7177-71-2-76-b13","series-title":"Anesth Pain Med","first-page":"409","article-title":"Effect of levetiracetam on rocuronium duration in patients undergoing cerebrovascular surgery","volume":"13","author":"Jeon YJ,","year":"2018","unstructured":"Jeon YJ,Kim MH. Effect of levetiracetam on rocuronium duration in patients undergoing cerebrovascular surgery. Anesth Pain Med. 2018;13(4):409\u2013414."},{"key":"i1878-7177-71-2-76-b14","series-title":"J Clin Anesth","first-page":"668","article-title":"Adducted vocal cords relieved by neuromuscular blocking drug: a cause of impaired mechanical ventilation when using a laryngeal mask airway: two photographically documented cases","volume":"26","author":"Ghimouz A,","year":"2014","unstructured":"Ghimouz A,Lentschener C,Goater P,Borne M,Esteve M. Adducted vocal cords relieved by neuromuscular blocking drug: a cause of impaired mechanical ventilation when using a laryngeal mask airway: two photographically documented cases. J Clin Anesth. 2014;26:668\u2013670."},{"key":"i1878-7177-71-2-76-b15","series-title":"J Anesth","first-page":"791","article-title":"Two cases of progressive vocal cord closure during desflurane-remifentanil anesthesia relieved after administration of propofol","volume":"27","author":"Kondo T,","year":"2013","unstructured":"Kondo T,Izumi H,Kuroda M,Kitagawa M. Two cases of progressive vocal cord closure during desflurane-remifentanil anesthesia relieved after administration of propofol. J Anesth. 2013;27:791\u2013792."},{"key":"i1878-7177-71-2-76-b16","series-title":"Article in Japanese. Masui","first-page":"1213","article-title":"Sudden vocal cord closure during general anesthesia using remifentanil","volume":"57","author":"Kohno T,","year":"2008","unstructured":"Kohno T,Ikoma M. Sudden vocal cord closure during general anesthesia using remifentanil. Article in Japanese. Masui. 2008;57:1213\u20131217."},{"key":"i1878-7177-71-2-76-b17","series-title":"Paediatr Anaesth","first-page":"133","article-title":"Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy","volume":"10","author":"Soriano SG,","year":"2000","unstructured":"Soriano SG,Kaus SJ,Sullivan LJ,Martyn JA. Onset and duration of action of rocuronium in children receiving chronic anticonvulsant therapy. Paediatr Anaesth. 2000;10:133\u2013136."},{"key":"i1878-7177-71-2-76-b18","series-title":"Clin Pharmacokinet","first-page":"71","article-title":"Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance","volume":"43","author":"Soriano SG,","year":"2004","unstructured":"Soriano SG,Martyn JA. Antiepileptic-induced resistance to neuromuscular blockers: mechanisms and clinical significance. Clin Pharmacokinet. 2004;43:71\u201381."},{"key":"i1878-7177-71-2-76-b19","series-title":"Ann Pharmacother","first-page":"554","article-title":"A mechanistic approach to antiepileptic drug interactions","volume":"32","author":"Anderson GD.","year":"1998","unstructured":"Anderson GD. A mechanistic approach to antiepileptic drug interactions. Ann Pharmacother. 1998;32:554\u2013563."},{"key":"i1878-7177-71-2-76-b20","series-title":"Eur J Clin Pharmacol","first-page":"441","article-title":"Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants","volume":"22","author":"Pirttiaho HI,","year":"1982","unstructured":"Pirttiaho HI,Sotaniemi EA,Pelkonen RO, et al. Hepatic blood flow and drug metabolism in patients on enzyme-inducing anticonvulsants. Eur J Clin Pharmacol. 1982;22:441\u2013445."},{"key":"i1878-7177-71-2-76-b21","series-title":"Br J Anaesth","first-page":"223","article-title":"Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy","volume":"86","author":"Soriano SG,","year":"2001","unstructured":"Soriano SG,Sullivan LJ,Venkatakrishnan K, et al. Pharmacokinetics and pharmacodynamics of vecuronium in children receiving phenytoin or carbamazepine for chronic anticonvulsant therapy. Br J Anaesth. 2001;86:223\u2013229."},{"issue":"1","key":"i1878-7177-71-2-76-b22","series-title":"Ther Drug Monit","first-page":"40","article-title":"The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro","volume":"26","author":"Bailey DN,","year":"2004","unstructured":"Bailey DN,Briggs JR. The binding of selected therapeutic drugs to human serum alpha-1 acid glycoprotein and to human serum albumin in vitro. Ther Drug Monit. 2004;26(1):40\u201343."},{"issue":"3","key":"i1878-7177-71-2-76-b23","series-title":"Anesthesiology","first-page":"500","article-title":"Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes","volume":"77","author":"Kim CS,","year":"1992","unstructured":"Kim CS,Arnold FJ,Itani MS,Martyn JA. Decreased sensitivity to metocurine during long-term phenytoin therapy may be attributable to protein binding and acetylcholine receptor changes. Anesthesiology. 1992;77(3):500\u2013506."},{"issue":"1","key":"i1878-7177-71-2-76-b24","series-title":"Anesthesiology","first-page":"82","article-title":"Systemic inflammation leads to resistance to atracurium without increasing membrane expression of acetylcholine receptors","volume":"98","author":"Fink H,","year":"2003","unstructured":"Fink H,Luppa P,Mayer B,Rosenbrock H, et al. Systemic inflammation leads to resistance to atracurium without increasing membrane expression of acetylcholine receptors. Anesthesiology. 2003;98(1):82\u201388."},{"issue":"5","key":"i1878-7177-71-2-76-b25","series-title":"Anesth Analg","first-page":"1362","article-title":"Nitric oxide is not a mediator of inflammation-induced resistance to atracurium","volume":"101","author":"Fink H,","year":"2005","unstructured":"Fink H,Bogdanski R,Luppa P,Martyn JAJ,Blobner M. Nitric oxide is not a mediator of inflammation-induced resistance to atracurium. Anesth Analg. 2005;101(5):1362\u20131367."},{"key":"i1878-7177-71-2-76-b26","series-title":"Crit Care Med","first-page":"275","article-title":"Fiber atrophy, but not changes in acetylcholine receptor expression, contributes to the muscle dysfunction after immobilization","volume":"27","author":"Ibebunjo C,","year":"1999","unstructured":"Ibebunjo C,Martyn JA. Fiber atrophy, but not changes in acetylcholine receptor expression, contributes to the muscle dysfunction after immobilization. Crit Care Med. 1999;27:275\u2013285."},{"key":"i1878-7177-71-2-76-b27","series-title":"Pharmacol Ther","first-page":"77","article-title":"Pharmacokinetic profile of levetiracetam: toward ideal characteristics","volume":"85","author":"Patsalos PN.","year":"2000","unstructured":"Patsalos PN. Pharmacokinetic profile of levetiracetam: toward ideal characteristics. Pharmacol Ther. 2000;85:77\u201385."},{"key":"i1878-7177-71-2-76-b28","series-title":"Clin Pharmacokinet","first-page":"707","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos PN.","year":"2012","unstructured":"Patsalos PN. Clinical pharmacokinetics of levetiracetam. Clin Pharmacokinet. 2012;43;707\u2013724."},{"key":"i1878-7177-71-2-76-b29","series-title":"Eur J Clin Pharmacol","first-page":"137","article-title":"Changes in the concentration of serum alpha 1-acid glycoprotein in epileptic patients","volume":"46","author":"Morita K,","year":"1994","unstructured":"Morita K,Yamaji A. Changes in the concentration of serum alpha 1-acid glycoprotein in epileptic patients. Eur J Clin Pharmacol. 1994;46:137\u2013142."},{"key":"i1878-7177-71-2-76-b30","series-title":"Anesth Pain Med","first-page":"122","article-title":"Updated review of resistance to neuromuscular blocking agents","volume":"13","author":"Jung KT,","year":"2018","unstructured":"Jung KT,An TH. Updated review of resistance to neuromuscular blocking agents. Anesth Pain Med. 2018;13:122\u2013127."},{"key":"i1878-7177-71-2-76-b31","series-title":"J Pharmacol Exp Ther","first-page":"443","article-title":"Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy","volume":"283","author":"Ibebunjo C,","year":"1997","unstructured":"Ibebunjo C,Nosek MT,Itani MS, et al. Mechanisms for the paradoxical resistance to d-tubocurarine during immobilization-induced muscle atrophy. J Pharmacol Exp Ther. 1997;283:443\u2013451."}],"container-title":["Anesthesia Progress"],"original-title":[],"link":[{"URL":"https:\/\/anesthesiaprogress.kglmeridian.com\/view\/journals\/anpr\/71\/2\/article-p76.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/anesthesiaprogress.kglmeridian.com\/downloadpdf\/journals\/anpr\/71\/2\/article-p76.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/anesthesiaprogress.kglmeridian.com\/downloadpdf\/journals\/anpr\/71\/2\/article-p76.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T00:01:57Z","timestamp":1746748917000},"score":1,"resource":{"primary":{"URL":"https:\/\/anesthesiaprogress.kglmeridian.com\/view\/journals\/anpr\/71\/2\/article-p76.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":31,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.2344\/23-00018","relation":{},"ISSN":["1878-7177","0003-3006"],"issn-type":[{"type":"electronic","value":"1878-7177"},{"type":"print","value":"0003-3006"}],"subject":[],"published":{"date-parts":[[2024,7]]}}}